MSC-seeded dense collagen scaffolds with a bolus dose of vegf promote healing of large bone defects

European Cells and Materials

Volumn 26, Issue , 2013, Pages 195-207

  Gao, C ^a   Harvey, E J ^a   Chua, M ^a,b   Chen, B P ^a   Jiang, F ^a   Liu, Y ^c   Li, A ^a   Wang, H ^a   Henderson, J E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Bone repair; Collagen scaffold; Mesenchymal stromal cells; Vascular endothelial growth factor

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN GEL; COLLAGEN TYPE 1; MINERAL; MOLECULAR SCAFFOLD; RECOMBINANT VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MARROW CELL; BONE MINERALIZATION; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL METABOLISM; CORTICAL BONE; DIAPHYSIS; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; IN VITRO STUDY; INCUBATION TIME; MALE; MESENCHYMAL STROMA CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOID;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCIUM PHOSPHATES; COLLAGEN; FEMUR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOGENESIS; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885939472     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v026a14     Document Type: Article

References (42)

1. Akhter MP, Iwaniec UT, Covey MA, Cullen DM, Kimmel DB, Recker RR (2000) Genetic variations in bone density, histomorphometry, and strength in mice. Calcif Tissue Intl 67: 337-344.
2. Amizuka N, Davidson D, Liu H, Valverde-Franco G, Chai S, Maeda T, Ozawa H, Hammond V, Ornitz DM, Goltzman D, Henderson JE (2004) Signalling by fbroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development. Bone 34: 13-25.
3. Aubin JE, Trifftt J (2002) Mesenchymal stem cells and the osteoblast lineage. In: Principles of Bone Biology (Bilezikian JP, Raisz LG, Rodan GA, eds), Academic Press, New York, pp 59-81.
4. Backer MV, Patel V, Jehning BT, Claffey KP, Backer JM (2006) Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials 27: 5452-5458.
5. Barralet J, Gbureck U, Habibovic P, Vorndran E, Gerard C, Doillon CJ (2009) Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng Part A 15: 1601-1609.
6. Bitar M, Brown RA, Salih V, Kidane AG, Knowles JC, Nazhat SN (2008) Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds. Biomacromolecules 9: 129-135.
7. Brown RA, Wiseman M, Chuo CB, Cheema U, Nazhat SN (2005) Ultrarapid engineering of biomimetic materials and tissues: fabrication of nano- and microstructures by plastic compression. Adv Funct Mater 15: 1762-1770.
8. Carlevaro MF, Cermelli S, Cancedda R, Cancedda FD (2000) Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: autocrine-paracrine role during endochondral bone formation. J Cell Sci 113: 59-69.
9. Gao C, Nguyen O, Serpooshan V, El Chaarani B, Nazhat SN, Harvey EJ, Henderson JE (2011) Rodent model of adult stem cell transplantation for bone repair. J Bone Joint Surg Br 93-B suppl IV: 553.
10. Gao C, Seuntjens J, Kaufman GN, Tran-Khan N, Butler A, Li A, Wang H, Buschmann MD, Harvey EJ, Henderson JE (2012) Mesenchymal stem cell transplantation to promote bone healing. J Orthop Res 30: 1183-1189.
11. Gbureck U, Holzel T, Doillon CJ, Muller FA, Barralet JE (2007) Direct printing of bioceramic implants with spatially localised angiogenic factors. Adv Mater 19: 795-800.
12. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003) Fracture healing as a post natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
13. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO (2006) Fracture healing in the elderly patient. Exp Gernotol 41: 1080-1093.
14. Harvey EJ, Henderson JE, Vengallatore ST (2010) Nanotechnology and bone healing. J Ortho Trauma 24: S25-S30.
15. Henderson JE, Gao C, Harvey EJ (2012) Skeletal phenotyping in rodents. In: Osteoporosis Research: Animal Models (Duque G, Watanabe K, eds), Springer-Verlag, London, pp. 13-28.
16. Herbertson A, Aubin JE (1995) Dexamethasone alters the sub-population makeup of bone marrow stromal cultures. J Bone Miner Res 10: 285-294.
17. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A (2006) Recombinant BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88: 1431-1441.
18. Joyce M (2005) Safety and FDA regulations for musculoskeletal allografts: perspective of an orthopaedic surgeon. Clin Orthop Relat Res 435: 22-30.
19. Kanczler JM, Oreffo RO (2008) Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
20. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406.
21. Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT (2008) Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 90: 36-42.
22. Kolambkar YM, Dupont KM, Boerckel JD, Huebsch N, Mooney DJ, Hutmacher DW, Guldberg RE (2011) An alginate based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32: 65-74.
23. Komori T (2010) Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 339: 189-195
24. Le Nihouannen D, Komarova SV, Gbureck U, Barralet JE (2008) Bioactivity of bone resorptive factor loaded on osteoconductive matrices: stability post-dehydration. Eur J Pharm Biopharm 70: 813-818.
25. Lin CY, Chang YH, Lin KJ, Yen TC, Tai CL, Chen CY, Lo WH, Hsaio IT, Hu YC (2010) The healing of critical sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 31: 3222-3230.
26. McKee MD, Sodek J (2000) Bone matrix proteins. In: The Osteoporosis Primer (Henderson JE, Goltzman D, eds), Cambridge University Press, Cambridge, pp 46-63.
27. Miyagi Y, Chiu LL, Cimini M, Weisel RD, Radisic M, Li RK (2011) Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 32: 1280-1290
28. Monfoulet L, Malaval L, Aubin JE, Rittling SR, Gadeau AP, Fricain JC, Chassande O (2010) Bone sialoprotein, but not osteopontin, defciency impairs the mineralization of regenerating bone during cortical defect healing. Bone 46: 447-452.
29. Moore DC, Chapman MW, Manske D (1987) The evaluation of biphasic calcium phosphate ceramic for use in grafting long bone diaphyseal defects. J Orthop Res 5: 356-365.
30. Nauth A, Miclau T, Bhandari M, Schemitsch EH (2011) Use of osteobiologics in the management of osteoporotic fractures. J Orthop Trauma 25: S51-55.
31. Oetgen ME, Richards BS (2010) Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop 30: 192-198.
32. Roohani-Esfahani SI, Lu ZF, Ellis-Behnke R, Kaplan DL, Zreiqat H (2012) Effect of self-assembled nanofbrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds. Acta Biomater 8: 302-312.
33. Rootare HM, Powers JM, Craig RG (1978) Sintered hydroxyapatite ceramic for wear studies. J Dent Res 57: 777-783.
34. Serpooshan V, Julien M, Nguyen O, Wang H, Li A, Muja N, Henderson JE, Nazhat SN (2010) Reduced hydraulic permeability of three-dimensional collagen scaffolds attenuates gel contraction and promoted the growth and differentiation of mesenchymal stem cells. Acta Biomater 6: 3978-3987.
35. Shen YH, Shoichet MS, Radisic M (2008) Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 4: 477-489.
36. Soundrapandian C, Datta S, Kundu B, Basu D, Sa B (2010) Porous bioactive glass scaffolds for local drug delivery in osteomyelitis: development and in vitro characterization. AAPS PharmSciTech 11: 1675-1683.
37. Starman JS, Bosse MJ, Cates CA, Norton HJ (2012) Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review. J Trauma Acute Care Surg 72: 676-681.
38. Street J, Bao M, deGuzman L, Bunting S, Peale FV, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661.
39. Tay BK, Le AX, Gould SE, Helms JA (1998) Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J Orthop Res 16: 636-642.
40. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanake M, Nagashima M, Nakamura T (2003) Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32: 491-501.
41. Valverde-Franco G, Liu H, Davidson D, Chai S, Valderrama-Carvajal H, Goltzman D, Ornitz DM, Henderson JE (2004) Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum Mol Genet 13: 271-284.
42. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA (2001) Covalently conjugated VEGF-fbrin matrices for endothelialization. J Control Release 72: 101-113.